RT Journal
A1 Mitka M
T1 COverage being questioned?
JF JAMA
JO JAMA
YR 2010
FD October 13
VO 304
IS 14
SP 1546
OP 1546
DO 10.1001/jama.2010.1417
UL http://dx.doi.org/10.1001/jama.2010.1417
AB 
CMS announced on August 31 that it would hold a meeting November 17 regarding on-label and off-label use of autologous cellular immunotherapy treatment of prostate cancer.